Characterising the cardioprotective potential of Sida rhombifolia, Polygonum chinense and Phyla nodiflora aqueous extracts: investigating its effect on foam cell formation Online publication date: Tue, 21-Jan-2025
by Xiao Wei Lee; Wei Sheng Siew; Siau Hui Mah; Wei Hsum Yap
International Journal of Bioinformatics Research and Applications (IJBRA), Vol. 21, No. 1, 2025
Abstract: Cardiovascular diseases represent one of the leading causes of mortality. Studies have shown that medicinal plants with anti-inflammatory and antioxidant activities are potential cardioprotective agents. This study aimed to determine cardioprotective potential of Sida rhombifolia, Polygonum chinense and Phyla nodiflora in inhibiting macrophage foam cells formation and its regulatory mechanisms. The findings showed that S. rhombifolia and P. nodiflora have minimal cytotoxicity effect on THP-1 macrophages, however P. chinense exhibited cytotoxic effect with an IC50 of 11.83 µg/mL. All plant extracts showed significant inhibition of foam cells formation at 10 µg/mL. PPI network and gene enrichment analysis showed that the three plant extracts may regulate the steroid biosynthesis and arachidonic acid metabolism, and MDM2, PTGS2, SIRT1, PARP1, RELA, GSK3B, CYP17A, and CYP19A1 were predicted as the targets. In conclusion, S. rhombifolia and P. nodiflora showed promising cardioprotective effect, which could be potential therapeutic treatment and prevention towards atherosclerosis.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Bioinformatics Research and Applications (IJBRA):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com